Human antibodies specific for polyribosyl-ribitol-phosphate (PRP), the capsular polysaccharide of Hemophilus influenzae b, were studied using idiotypic analysis. Antisera were prepared against purified F(ab')2 anti-PRP from two unrelated adults, H.H. and P.T. After repeated absorption with IgG myeloma proteins and with PRP-absorbed normal human Ig and donor Ig, anti-idiotypic (anti-Id) sera were obtained that specifically reacted with anti-PRP antibodies. Anti-IdHH and anti-Id"' reciprocally crossreacted with H.H. and P.T. anti-PRP antibodies and F(ab)2 fragments, and also reacted with the serum anti-PRP antibodies from three additional adults unrelated to P.T. and H.H. Both anti-Id sera partially inhibited anti-PRP paratopes but not anti-tetanus toxoid paratopes. PRP did not inhibit anti-Id recognition of shared or crossreactive idiotypic (CRI) determinants. Naturally occurring and PRP immunization-induced anti-PRP antibodies expressed CRI. While CRI titer increased after immunization, the increase was usually less than the rise in total anti-PRP antibody. Quantitative differences in CRI expression were also apparent between natural and immunization-induced H.H. and P.T. anti-PRP antibodies as shown by their differential inhibitability by anti-Id. Our data demonstrate that anti-PRP antibodies from five unrelated adults express CRI determinants that are probably distant from the PRP combining site. Naturally occurring and immunization-induced anti-PRP antibodies share CRI and therefore appear to be clonally related, although immunization apparently induces the expression CRInegative antibodies as well. These results, taken with previous studies showing restricted and identical anti-PRP isoelectric focusing spectrotypes in unrelated adults, suggest that some PRP-specific V domains are structurally conserved and probably germ-line encoded.
Introduction
The encapsulated bacterium, Hemophilus influenzae b (Hib),' is the primary cause of meningitis in the United States and is Dr. Lucas's current address is Dept. of Immunology, IMM the etiologic agent in other serious invasive diseases (1) . Serum antibodies specific for the Hib capsular polysaccharide, polyribosyl-ribitol-phosphate (PRP), confer resistance to Hib infection and, like antibodies to many other bacterial polysaccharides, their expression is age related. Children < 2 yr of age generally synthesize little anti-PRP antibody either spontaneously or in response to parenteral immunization with PRP, whereas older children and adults have protective levels of so-called natural antibody and upon immunization they respond with increased levels of specific antibody (2) (3) (4) (5) (6) .
Elucidating the mechanisms involved in the ontogeny and regulation of the PRP-specific antibody response requires information as to the repertoire size. Recent progress was made in this area by Insel et al., who used isoelectric focusing (IEF) analysis to show that human antibodies to PRP were oflimited structural diversity (7, 8) . Anti-PRP IEF patterns consisted of only a few predominant spectrotypes, and in some cases they appeared as restricted as monoclonal antibody. Moreover, the spectrotypes of unrelated individuals were remarkably similar. These findings indicate that the anti-PRP antibody response is pauciclonal and is composed of structurally conserved molecules.
Another approach to assess the diversity of the anti-PRP antibody repertoire is by characterization of idiotypes (Ids) . Idiotypic analysis could provide insight into the question of whether the limited polymorphism observed with IEF is due to variable region restriction. Such knowledge might help clarify the mechanisms generating anti-PRP antibody diversity in humans, and also could provide an experimental system in humans for addressing the issue of Id regulation and the possible role it may play in the ontogeny of anti-carbohydrate immunity. Studies in several experimental systems have demonstrated that anti-Id antibodies can induce specific immunity to infectious agents (9) (10) (11) (12) (13) (14) . This strategy, which may be feasible for inducing human An inhibition ELISA was used to assess specificity ofanti-Id and to quantitate Id. A dilution of anti-Id giving an OD of -0.4 in the direct binding assay (1:400 for anti-IdHH and 1:1,600 for anti-Id') was incubated with varying concentrations of inhibitors for 2 h at 37°C, after which the mixtures were added to microtiter wells previously coated with HH anti-PRP (IdHH) or PT anti-PRP (Id'r) and blocked with PBS-BSA. The plates were incubated for 3 h at 37°C, washed, then incubated with goat anti-mouse Ig antibodies coupled with alkaline phosphatase. After 3 h at 37°C, the wells were washed and developed as described above. Color development proceeded until an OD of -0.5 was obtained in the absence ofinhibitor. All samples were tested in duplicate. Results are expressed as percent inhibition of anti-Id binding and were calculated according to: % inhibition = 100 X I -(OD with inhibitor)/(OD no inhibitor).
ELISA assay for PRP-specific and tetanus toxoid (TT)-specific antibodies. Dilutions of sera, Ig preparations, or purified antibodies were added to microtiter wells that had been coated with PRP-tyramine (17) (3 ug/ml PBS, 3 h at 37°C) and blocked with PBS-BSA. After 3 h at 37°C or overnight at 4°C, the wells were washed, then polyvalent goat anti-human Ig antibodies coupled with alkaline phosphatase (Tago, Inc.) were added for 3 h at 37°C. The wells were washed and developed as described above. All samples were tested in duplicate. The concentration of anti-PRP antibody was determined by comparison to a standard curve generated by a reference human anti-PRP serum containing 70 Ag anti-PRP antibody/ml (provided by Dr. John Robbins, National Institutes of Health, Bethesda, MD). Background OD, generated by test samples incubated on BSA-coated wells, was subtracted from OD generated on PRP-coated wells. This assay has a sensitivity of 0.02 Mg anti-PRP antibody/ml. The assay is specific for anti-PRP antibodies, since all binding is inhibited by preincubation of sera with PRP but not with unrelated polysaccharides, and since absorption with PRP-Sepharose specifically removes binding activity.
Human antibodies specific for TT were measured as described in reference 18.
Results
Binding of anti-Id to purified anti-PRP antibodies. Murine antisera were prepared against purified F(ab')2 anti-PRP from two unrelated adults, H.H. and P.T. After absorption of the antisera with Sepharose coupled with human IgG myeloma protein, PRP-absorbed normal human Ig, and with PRP-absorbed donor Ig, anti-IdHH and anti-id'P were tested for their ability to bind to microtiter wells coated with anti-PRP antibodies (Id) or with PRP-absorbed Ig. Fig. 1 The same Ig preparations were tested for their ability to inhibit the reaction of anti-Id' with either Id' or IdHH. As shown in Fig. 3, both (Fig. 4 B) . AntiIdPT was similarly tested, and neither the homologous nor the heterologous reaction was susceptible to PRP inhibition. Crossreactive idiotypes (CRI) and anti-PRP titers ofpreand post-PRP vaccination sera. The pre-and post-PRP vaccination sera from H.H., P.T., and three additional unrelated subjects were tested quantitatively for CR1, using the inhibition ELISA, and for total anti-PRP antibody using the PRPreactive ELISA. As shown in Table II predominantly anti-Id specificities reactive with public or CRI determinants. Consistent with this interpretation are the findings that Id" was 10-fold more efficacious as an inhibitor of the anti-IdHH IdP1 reaction than of the anti-IdHH _) IdHH reaction, whereas IdHH had equivalent inhibitory activity in both the anti-Id' --Id'Tand anti-Id' --IdHH reactions.
The interpretation of Id crossreactivity depends critically upon the nature of the interaction between anti-Id and anti-PRP antibodies. The anti-Ids could be functioning as conventional anti-CRI antibodies, i.e., they are recognizing conserved Id determinants shared between structurally similar V domains. Alternatively, the anti-Ids could be recognized by anti-PRP antibodies because the anti-Ids themselves express Id determinants which behave, at least functionally, like socalled internal images of PRP. Ligand inhibition of anti-Id --Id reactions is a necessary condition for internal image-type anti-Ids. Since the recognition ofCRI determinants, as defined by the interaction between anti-Id and heterologous anti-PRP antibodies (Id), was not inhibitable by PRP, it appears that the anti-CRI specificities were not functioning as PRP internal images. We therefore interpret the observed Id crossreactivity in terms of anti-Id recognition ofId determinants expressed by structurally related anti-PRP V domains. This view is supported by the IEF studies of Insel et al., which demonstrated restricted and frequently identical anti-PRP spectrotypes among unrelated individuals (7) . Taken together, our data and those of Insel et al., suggest that the adult antibody response to PRP is composed of a limited number of conserved V regions that may be germ-line encoded.
Unlike several well-studied murine CRIs which serve as markers for one or a few homologous germ-line VH genes (19) (20) (21) ) and whose expression is generally linked to particular IgH alleles, the expression of anti-PRP-associated CRI appears not to be genetically restricted, since CRI was present in five of five unrelated individuals. Since we have not tested Ig allotypes we cannot exclude the possibility that the subjects were identical at the relevant Ig loci, although this seems improbable. Rather, we suggest that the VH and/or VL genes responsible for CRI expression may be ubiquitous in the germ-line. A similar lack of genetic restriction has been observed with murine anti-poly-(Glu',L-Ala3o,L-Tyr6") antibodies (22) and human antibodies to N-acetyl-D-glucosamine (23) . Further studies with a larger panel of subjects are required in order to define the extent of anti-PRP-associated CRI penetrance and to determine whether CRI expression is influenced by genetic determinants such as the Km and Gm allotypes, which have been implicated in regulating the antibody response to PRP (24, 25) and in affecting susceptibility to Hib infection (26) .
The structural basis of CRI expression has yet to be determined. Particular VH or VL hypervariable region sequences may be involved, as has been shown for the CRIs expressed by murine anti-a (1-3) dextran antibodies (27) The CRIs defined by the heterologous anti-Id --Id reactions were expressed by both naturally occurring and immunization-induced antibodies, implying that the clonal origins of these two populations may overlap to some degree. This finding is consistent with previous studies showing that IEF spectrotype patterns of "natural" and immunization-induced anti-PRP antibodies were often similar, although occasionally new clonotypes appeared after immunization (7). Our results show that while CRI serum titer increased after PRP immunization (with the exception of H.H., see below), it did not always parallel the increase in the total anti-PRP antibody titer, suggesting that the fraction of the total antibody that was CRI positive diminished after immunization. This apparent diminution may be due to the emergence ofCRI-negative antibodies, i.e., new clonotypes, or to the extinction of CRI determinants by somatic mutation or active suppression. Note that individual HH did not show an increase in serum CRI titer (as defined by anti-IdHH --Id') after PRP immunization despite a fourfold increase in total anti-PRP antibody. Although the anti-IdHH antiserum was prepared against H.H. anti-PRP antibodies isolated from the postimmunization serum, the anti-CRI reactivity of this antiserum was with Ids that predominated the preimmunization antibody population, but which were also present in the postimmunization population.
The experiments examining the inhibition of anti-PRP paratopes with anti-Id are informative for several reasons. First, the results confirm the specificity of the anti-Id reagents, since anti-PRP but not anti-TT paratopes were inhibited. Second, they are consistent with the finding of the ELISA inhibition assays, showing that quantitative changes in serum Id composition occur as a result of PRP immunization. For example, the fraction of anti-PRP paratopes inhibitable by antiIdPT diminished in H.H. serum after PRP immunization, again suggesting that CRI predominated the preimmunization H.H. antibody population. Third, the inhibition of heterologous anti-PRP paratopes by anti-Id is a further demonstration of the Id crossreactivity between H.H. and P.T. anti-PRP antibodies. Fourth, the degree of inhibition of anti-PRP paratopes inhibitable by heterologous anti-Id provides a minimal estimate ofthe fraction ofthe total anti-PRP antibody population expressing CRI, which for P.T. postimmunization antibodies was 43% and for H.H. preimmunization antibodies was -38%. These high values indicate that CRI-positive antibodies can comprise a major proportion of the total antibody population and lend further support to the notion that a restricted number of V regions predominates the PRP-specific antibodies of these individuals.
The polyclonal anti-Id antisera used in this study were made in mice so that in the future monoclonal anti-Id antibodies can be isolated. Such reagents are necessary for definition of the idiotopes comprising the CRI families recognized by antiIdHH and anti-IdPT. Monoclonal anti-Ids would also be useful for investigating the feasibility of an anti-Id Hib vaccine. Both polyclonal and monoclonal anti-Id antibodies have been used successfully in animal models to induce protective immunity to parasites (9) , viruses (10-12), and bacteria (13, 14 
